Fox Health

Across Africa and Southeast Asia, governments and aid groups, as well as the World Health Organization, are calling on pharmaceutical companies to share their patent information more broadly to meet a yawning global shortfall in a pandemic that already has claimed over 2.5 million lives.

After a year of struggling to boost testing, communities across the country are seeing plummeting demand, shuttering testing sites or even trying to return supplies.

How many servings of fruits and veggies should you be getting each day? A new study published in Circulation, the journal of the American Heart Association, aims to provide an answer. 

California has continued to experience difficulty with its vaccine distribution program.

The United States will soon begin screening travelers who come from countries with cases of Ebola, an often deadly virus that causes severe bleeding and organ failure. 

Federal officials overseeing the country’s vaccination effort are placing a strong emphasis on an equitable and even distribution of jabs across all communities. During a White House briefing Monday, officials warned of intervening amid any inequities in the rollout.

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, on Monday urged a close watch of a coronavirus variant recently detected in New York.

The Food and Drug Administration (FDA) issued an emergency use authorization on Monday for a rapid at-home COVID-19 test that delivers results without the use of an outside laboratory.

Johnson & Johnson’s single-shot COVID-19 vaccine will begin shipping in the U.S. on Monday morning, marking the third shot in the country’s arsenal after a greenlight from the FDA and a panel with the Centers for Disease Control and Prevention.

The vaccines have shown to significantly decrease the overall community spread.

A U.S. Food and Drug Administration advisory panel on Friday voted to endorse Johnson & Johnson’s coronavirus vaccine, clearing the way for FDA leaders to grant emergency use authorization amid the ongoing fight against COVID-19.

A U.S. Food and Drug Administration advisory committee on Friday is slated to vote on Johnson & Johnson’s one-dose COVID-19 jab, with the panel expected to recommend that the FDA formally grant the shot emergency use approval in a race to vaccinate as many Americans as possible in the continued fight against the novel coronavirus.

An endorsement from an independent group of experts and an emergency use authorization from the Food and Drug Administration would spark a rollout of up to 4 million jabs across the U.S. early next week.

A third COVID-19 vaccine could enter the fight against the novel virus in the coming days. But what does its safety profile look like?

A coronavirus vaccine developed by Johnson & Johnson could potentially clear U.S. regulatory hurdles over the next day, and authorization would mark the third jab in the country’s arsenal against the novel virus.

The coronavirus variant first detected in the U.K. late last year now accounts for up to 10% of COVID-19 cases in the U.S., officials said Friday.

Annie’s Homegrown, largely known for its macaroni and cheese, is taking steps to remove a potentially harmful class of chemicals, called ortho-phthalates from its products and packaging materials. 

Moderna has completed enrollment for a Phase 2/3 study of its COVID-19 vaccine in adolescents ages 12 to 17.

The Food and Drug Administration (FDA) said Thursday it is allowing more flexible shipping and storage temperatures for the Pfizer-BioNTech coronavirus vaccine. The change permits transportation and two-week storage at -25 degrees Celsius to -15 degrees Celsius, which is often found in pharmaceutical freezers and refrigerators. 

How would COVID-19 vaccine makers adapt to variants? By tweaking their vaccines, a process that should be easier than coming up with the original shots.